850081P

Monolyso Heart CA

Avanti Research^™ - A Croda Brand 850081P, powder

• Synonym(e): monolysocardiolipin (Heart, Bovine) (sodium salt)
• CAS-Nummer: 383907-65-1
• UNSPSC-Code: 12352211
• NACRES: NA.25

Eigenschaften

• Assay: >99% (TLC)
• Form: powder
• Verpackung: pkg of 1 × 10 mg (850081P-10mg)
• Hersteller/Markenname: Avanti Research^™ - A Croda Brand 850081P
• Lipid-Typ: phosphoglycerides
• Versandbedingung: dry ice
• Lagertemp.: −20°C
• SMILES String: O=P([O-])(OC[C@]([H])(O)COC(CCCCCCC/C=C\C/C=C\CCCCC)=O)OCC([H])(O)COP([O-])(OC[C@]([H])(OC(CCCCCCC/C=C\C/C=C\CCCCC)=O)COC(CCCCCCC/C=C\C/C=C\CCCCC)=O)=O.[Na+].[Na+]

Beschreibung

Allgemeine Beschreibung

Monolysocardiolipin (MLCL) is a class of phospholipid related to cardiolipin. MLCL is a triacylated phospholipid, uncommon in bacterial or eukaryotic membranes. MLCL is prepared from cardiolipin by the hydrolysis action of phospholipase A2 (PLA2).

Anwendung

Monolyso Heart CA is suitable for use:

• as substrate for the synthesis of cardiolipin by the enzyme acyl-CoA:lysocardiolipin acyltransferase (ACLAT1)
• as substrate for the assay of mitochondrial monolysocardiolipin acyltransferase (MLCL AT) activity
• in the preparation of affinity resin MLCL-adriamycin-agarose for the purification of MLCL AT

Biochem./physiol. Wirkung

Monolysocardiolipin (MLCL) is a substrate for the biosynthesis of cardiolipin in heart by the activity of MLCL acyltransferase. MLCL is a marker for Barth syndrome. MLCL is implicated in apoptosis.

Verpackung

5 mL Clear Glass Sealed Ampule (850081P-10mg)

Rechtliche Hinweise

Avanti Research is a trademark of Avanti Polar Lipids, LLC

Sicherheitshinweise

• Lagerklassenschlüssel: 11 - Combustible Solids
• WGK: WGK 3